{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:48:38Z","timestamp":1774489718170,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.humpath.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T23:47:25Z","timestamp":1511308045000},"page":"180-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma"],"prefix":"10.1016","volume":"72","author":[{"given":"Radwa","family":"El Behery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier A.","family":"Laurini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis D.","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynette M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavana J.","family":"Dave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat N.","family":"Nathwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip J.","family":"Bierman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Bociek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Vose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C.","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Aoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2017.11.002_bb0005","series-title":"SEER cancer statistics review, 1975-2013","year":"2016"},{"key":"10.1016\/j.humpath.2017.11.002_bb0010","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM198711053171904","article-title":"Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas","volume":"317","author":"Weiss","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2017.11.002_bb0015","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.2009.81","article-title":"t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region","volume":"22","author":"Gu","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2017.11.002_bb0020","series-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","first-page":"220","article-title":"Follicular lymphoma","author":"Harris","year":"2008"},{"key":"10.1016\/j.humpath.2017.11.002_bb0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hon.2900010209","article-title":"Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method","volume":"1","author":"Mann","year":"1983","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.humpath.2017.11.002_bb0030","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/annonc\/mdl039","article-title":"Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience","volume":"17","author":"Ganti","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2017.11.002_bb0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/annonc\/mdm511","article-title":"The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma","volume":"19","author":"Overman","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2017.11.002_bb0040","first-page":"1","article-title":"New approaches to the classification of the lymphomata","volume":"2","author":"Lukes","year":"1975","journal-title":"Br J Cancer Suppl"},{"key":"10.1016\/j.humpath.2017.11.002_bb0045","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2017.11.002_bb0050","series-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues: World Health Organization classification of tumours","first-page":"162","article-title":"Follicular lymphoma","author":"Nathwani","year":"2001"},{"key":"10.1016\/j.humpath.2017.11.002_bb0055","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood-2002-07-2298","article-title":"A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic sybtypes do not predict survival","volume":"101","author":"Hans","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2017.11.002_bb0060","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2017.11.002_bb0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cancergencyto.2004.01.008","article-title":"Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults","volume":"153","author":"Dave","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2017.11.002_bb0070","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2017.11.002_bb0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.humpath.2017.11.002_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2017.11.002_bb0085","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2006.10.5833","article-title":"Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group","volume":"25","author":"Klapper","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2017.11.002_bb0090","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2017.11.002_bb0095","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/01.pas.0000172191.87176.3b","article-title":"Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features","volume":"29","author":"Wang","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.11.002_bb0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.clml.2017.06.006","article-title":"Rituximab improves the outcome of patients with grade 3 follicular lymphoma receiving anthracycline-based therapy","volume":"17","author":"Yuan","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717304082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717304082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T04:31:07Z","timestamp":1530246667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817717304082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":20,"alternative-id":["S0046817717304082"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2017.11.002","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}